SCHEMBL2216976

SCHEMBL2216976

CCCCCCCCCCCCCCOC1COC(c2ccccc2)OC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.40
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
HCRTR2 O43614 1/20 0.38
MEN1 O00255 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
LTA4H P09960 1/20 0.37
GBA1 P04062 1/20 0.37
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
PTAFR P25105 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799158 1.00 PPARG (0.40) PPARGALDH1A1TSHRLMNATDP1
SCHEMBL2215031 1.00 PPARG (0.40) PPARGALDH1A1TSHRLMNATDP1
SCHEMBL11663818 1.00 PPARG (0.40) PPARGALDH1A1TSHRLMNATDP1
SCHEMBL2219048 1.00 PPARG (0.40) PPARGALDH1A1TSHRLMNATDP1
SCHEMBL18612429 0.94 MEN1 (0.40) PPARGTSHRTDP1HCRTR2MEN1
SCHEMBL12369625 0.92 MEN1 (0.43) TSHRTDP1HCRTR2MEN1CYP2C19
SCHEMBL2219973 0.92 SOAT2 (0.37) PPARGHCRTR2FAAH
SCHEMBL7108821 0.88 ALDH1A1 (0.37) ALDH1A1
SCHEMBL2361796 0.88 MEN1 (0.42) ALDH1A1TSHRHCRTR2MEN1CYP2C19
SCHEMBL8974955 0.84 TP53 (0.51) TSHRMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110177156-A1 Sterol-Modified Amphiphilic Lipids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-07-21 US disclosed
CN-101909581-A Sterol-modified amphiphilic lipids UNIV CALIFORNIA 2010-12-08 CN disclosed
EP-2219587-A1 STEROL-MODIFIED AMPHIPHILIC LIPIDS The Regents of the University of California (US) 2010-08-25 EP disclosed
WO-2009064696-A1 STEROL-MODIFIED AMPHIPHILIC LIPIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177156-A1 Sterol-Modified Amphiphilic Lipids SREBF1, SREBF2, SGMS1 PPARG 125/4885ALDH1A1 4359/4885TSHR 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.